SEARCH

SEARCH BY CITATION

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

FilenameFormatSizeDescription
mnfr1969-sup-0001-Supmate.ppt707K

Table S1. Body weight and tissue weight of KK-Ay mice. The food intakes, body weights, the weights of the mesenteric, renal, subcutaneous, and epididymal white adipose tissue (WAT), skeletal muscle, liver, kidney, and brown adipose tissue (BAT) of each group were presented. The control group is untreated KK-Ay mice (HFD). The values are means + S.E. (n=5). * p < 0.05, ** p < 0.01 compared with the untreated group.

Figure S1. DSE suppressed TG accumulation in FAO and primary hepatocytes. Lipid accumulation in FAO (A) and primary hepatocytes (B) treated with 10 or 30 mg/ml DSE. Accumulated lipid was measured 48 h after the addition of each compound. GW7647 (1 mM) was used as the positive control for PPARa activation. Each bar represents the mean ± S.E. (n=6-7). * p < 0.05, compared with the vehicle control.

Figure S2. Effect of DSE on FA oxidation in FAO and primary hepatocytes. [14C]-CO2 release (A, C) and [14C]-ASM release (B, D) of b-oxidation hepatocytes treated with 10 or 30 mg/ml DSE. Each bar represents the mean ±S.E. (n=4-5). * p < 0.05, ** p < 0.01 compared with the vehicle control.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.